12 January 2024
Hogan Lovells advises Omega Therapeutics on research collaboration transaction with Novo Nordisk and Flagship Pioneering
Advising firms
Deal team
5 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Cullen Taylor Lead | Hogan Lovells | Partner | Not stated | Northern Virginia |
| Stephen Nicolai Lead | Hogan Lovells | Partner | Not stated | Philadelphia |
| Melissa Schwaller | Hogan Lovells | Senior associate | Not stated | Houston |
| Daniel Davidson | Hogan Lovells | Counsel | Not stated | Washington, D.C. |
| Estefania McCarroll | Hogan Lovells | Associate | Not stated | Northern Virginia |
Stated terms
- Stated value
- Not stated
- What the figure measures
- Not stated
- Client
- Omega Therapeutics, Inc.Joint venture party
- Counterparties
- Novo Nordisk (Joint venture party)
Flagship Pioneering (Joint venture party)